The current in vivo evidence clearly demonstrates that suppressing LPA1 activity is effective for acute brain injury in cerebral ischemia, but it remains unclear whether this effect is linked to a long-term protection. This evidence concerns the gene LPAR1 and Cerebral ischemia.